Comparison of Cervical-lymph-node-first Presentation of Kawasaki Disease and Typical Kawasaki Disease

Hye-Won YUN; Jun-Yeol LEE; Song-I YANG; Hee-Joon YU; Min-Jae KANG; So-Yeon LEE; Hae-Ran LEE; Kwang-Nam KIM; Sung-Hye KIM.
Pediatric Infection & Vaccine ; : 10-17, 2016.
Artículo en Ko | WPRIM | ID: wpr-87526

Documentos relacionados

  1. [Clinical details in the diagnosis of Kawasaki disease].
  2. Indicators of Oxidative Stress in the Prediction of Coronary Artery Lesions in Patients With Kawasaki Disease.
  3. [Diagnosis and treatment of incomplete Kawasaki disease in children].
  4. [Interpretation of the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease].
  5. Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay.
  6. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
  7. Mucocutaneous lymph node syndrome: a new clinical entity.
  8. Potential roles of NLRP3 inflammasome in the pathogenesis of Kawasaki disease.
  9. Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature.
  10. Utilizing single-cell RNA sequencing for analyzing the characteristics of PBMC in patients with Kawasaki disease.